Literature DB >> 22375041

Natural history definition and a suggested clinical approach to Buerger's disease: a case-control study with survival analysis.

Bahare Fazeli1, Hassan Ravari, Reza Assadi.   

Abstract

The aim of this study was first to describe the natural history of Buerger's disease (BD) and then to discuss a clinical approach to this disease based on multivariate analysis. One hundred eight patients who corresponded with Shionoya's criteria were selected from 2000 to 2007 for this study. Major amputation was considered the ultimate adverse event. Survival analyses were performed by Kaplan-Meier curves. Independent variables including gender, duration of smoking, number of cigarettes smoked per day, minor amputation events and type of treatments, were determined by multivariate Cox regression analysis. The recorded data demonstrated that BD may present in four forms, including relapsing-remitting (75%), secondary progressive (4.6%), primary progressive (14.2%) and benign BD (6.2%). Most of the amputations occurred due to relapses within the six years after diagnosis of BD. In multivariate analysis, duration of smoking of more than 20 years had a significant relationship with further major amputation among patients with BD. Smoking cessation programs with experienced psychotherapists are strongly recommended for those areas in which Buerger's disease is common. Patients who have smoked for more than 20 years should be encouraged to quit smoking, but should also be recommended for more advanced treatment for limb salvage.

Entities:  

Mesh:

Year:  2012        PMID: 22375041     DOI: 10.1258/vasc.2011.oa0323

Source DB:  PubMed          Journal:  Vascular        ISSN: 1708-5381            Impact factor:   1.285


  4 in total

1.  How Can We Balance Ethics and Law When Treating Smokers?

Authors:  Helen Senderovich
Journal:  Rambam Maimonides Med J       Date:  2016-04-19

2.  Thromboangiitis obliterans episode: autoimmune flare-up or reinfection?

Authors:  Mehran Mohareri; Ali Mirhosseini; Saeedeh Mehraban; Bahare Fazeli
Journal:  Vasc Health Risk Manag       Date:  2018-09-28

3.  Long-Term Outcome and Prognostic Factors of Complications in Thromboangiitis Obliterans (Buerger's Disease): A Multicenter Study of 224 Patients.

Authors:  Alexandre Le Joncour; Simon Soudet; Axelle Dupont; Olivier Espitia; Fabien Koskas; Philippe Cluzel; Pierre Yves Hatron; Joseph Emmerich; Patrice Cacoub; Matthieu Resche-Rigon; Marc Lambert; David Saadoun
Journal:  J Am Heart Assoc       Date:  2018-12-04       Impact factor: 5.501

Review 4.  Thromboangiitis obliterans (Buerger's disease).

Authors:  Ignacio J Rivera-Chavarría; José D Brenes-Gutiérrez
Journal:  Ann Med Surg (Lond)       Date:  2016-03-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.